Harmony Biosciences Earnings
NASDAQ: HRMYHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Tue, Nov 3, 2026
Fiscal period
Sep/2026
EPS estimate
$1.03
Harmony Biosciences earnings summary
Harmony Biosciences is scheduled to report Sep/2026 earnings on Nov 3, 2026, with analysts expecting EPS of $1.03. In its most recent report on Aug 4, 2026 (Q2 2026), HRMY posted EPS of $1.28. Revenue for the quarter was $261.3 million.
Quarterly EPS is up 88.2% from the same quarter a year earlier. Across the last 16 reports, HRMY shares moved an average of 4.0% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
HRMY earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 4, 2026 | — | $1.28 | — | -0.8% |
| May 7, 2026 | — | $0.55 | — | -2.9% |
| Feb 24, 2026 | — | $0.38 | — | -0.7% |
| Nov 4, 2025 | — | $0.87 | — | +8.3% |
| Aug 5, 2025 | — | $0.68 | — | +7.8% |
| May 6, 2025 | — | $0.78 | — | +3.0% |
| Feb 25, 2025 | — | $0.85 | — | -0.5% |
| Oct 29, 2024 | — | $0.79 | — | +9.1% |
| Aug 6, 2024 | — | $0.20 | — | +3.3% |
| Apr 30, 2024 | — | $0.67 | — | -4.5% |
| Feb 22, 2024 | — | $0.46 | — | -1.2% |
| Oct 31, 2023 | — | $0.63 | — | -8.3% |
| Aug 1, 2023 | — | $0.56 | — | -5.0% |
| May 2, 2023 | — | $0.48 | — | +0.8% |
| Feb 21, 2023 | — | $0.79 | — | -4.6% |
| Nov 1, 2022 | — | $1.44 | — | -3.3% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.